Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease
暂无分享,去创建一个
Eric M. Blalock | Philip W. Landfield | E. Blalock | J. Geddes | P. Landfield | Heather M Buechel | J. Popović | Heather M. Buechel | Jelena Popovic | James W. Geddes
[1] G. Johnson,et al. Tau, where are we now? , 2002, Journal of Alzheimer's disease : JAD.
[2] Olivier Thibault,et al. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.
[3] M. Ball,et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.
[4] D. Butterfield,et al. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. , 2007 .
[5] A. Granholm,et al. Nerve growth factor in treatment and pathogenesis of Alzheimer's disease , 2006, Progress in Neurobiology.
[6] Roberta Diaz Brinton,et al. Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. , 2008, Advanced drug delivery reviews.
[7] G. Casadesus,et al. A Metabolic Basis for Alzheimer Disease , 2003, Neurochemical Research.
[8] J. Heath,et al. Gene expression profiling of RNA extracted from FFPE tissues: NuGEN technologies' whole-transcriptome amplification system. , 2011, Methods in molecular biology.
[9] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] T B Shea,et al. Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.
[11] Douglas Walker,et al. Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.
[12] G. Pasinetti,et al. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia , 2001, Journal of neuroscience research.
[13] E. Blalock,et al. Disrupting Function of FK506-Binding Protein 1b/12.6 Induces the Ca2+-Dysregulation Aging Phenotype in Hippocampal Neurons , 2011, The Journal of Neuroscience.
[14] Ron Edgar,et al. Gene Expression Omnibus ( GEO ) : Microarray data storage , submission , retrieval , and analysis , 2008 .
[15] John Q Trojanowski,et al. ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.
[16] P. Bickford,et al. Diets Enriched in Foods with High Antioxidant Activity Reverse Age-Induced Decreases in Cerebellar β-Adrenergic Function and Increases in Proinflammatory Cytokines , 2002, The Journal of Neuroscience.
[17] T. Triche,et al. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. , 2010, The Journal of molecular diagnostics : JMD.
[18] Ilya Bezprozvanny,et al. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.
[19] Meaghan Morris,et al. The Many Faces of Tau , 2011, Neuron.
[20] C. Dobson,et al. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.
[21] S. Scheff,et al. Alzheimer's disease-related synapse loss in the cingulate cortex. , 2001, Journal of Alzheimer's disease : JAD.
[22] P. Coleman,et al. Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.
[23] N. Sewankambo,et al. Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues. , 2010, Analytical biochemistry.
[24] G. Gibson,et al. Calcium and the aging nervous system , 1987, Neurobiology of Aging.
[25] F. LaFerla,et al. Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models , 2007, Annals of the New York Academy of Sciences.
[26] E. Barrett-Connor,et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.
[27] Z. Khachaturian. The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.
[28] A. Stromberg,et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation , 2005, Ageing Research Reviews.
[29] J. Trojanowski,et al. Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.
[30] B. Yankner,et al. Neural mechanisms of ageing and cognitive decline , 2010, Nature.
[31] F. Sohrabji,et al. Estrogen–BDNF interactions: Implications for neurodegenerative diseases , 2006, Frontiers in Neuroendocrinology.
[32] E. Mufson,et al. Single cell gene expression profiling in Alzheimer’s disease , 2006, NeuroRX.
[33] R. Weindruch,et al. Microglia and Aging in the Brain , 2002 .
[34] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[35] P. Mathews,et al. The neuronal endosomal-lysosomal system in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.
[36] P. Landfield. ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.
[37] M. Milisavljević,et al. Microvascular anatomy of the hippocampal formation. , 1992, Surgical neurology.
[38] T. Arendt,et al. Activated Mitogenic Signaling Induces a Process of Dedifferentiation in Alzheimer's Disease That Eventually Results in Cell Death , 2000, Annals of the New York Academy of Sciences.
[39] Suzanne Craft,et al. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. , 2007, Current Alzheimer research.
[40] J F Disterhoft,et al. The Calcium Rationale in Aging and Alzheimer's Disease , 1994, Annals of the New York Academy of Sciences.
[41] Kazuyuki Takata,et al. Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.
[42] D. Gustafson. Adiposity indices and dementia , 2006, The Lancet Neurology.
[43] Aristide Merola,et al. Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter , 2009, Journal of neuropathology and experimental neurology.
[44] M. Michaelis,et al. Decreased plasma membrane calcium transport activity in aging brain. , 1996, Life sciences.
[45] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[46] E. Mufson,et al. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. , 2007, Current Alzheimer research.
[47] J M Lee,et al. A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.
[48] R. Boyce,et al. Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[49] B. Hyman,et al. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.
[50] P. Bickford,et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats , 2000, Brain Research.
[51] Vicki Olm,et al. Statin therapy for Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.
[52] D. Morgan. Learning and Memory Deficits in APP Transgenic Mouse Models of Amyloid Deposition , 2003, Neurochemical Research.
[53] R. Bowser,et al. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. , 2002, Journal of Alzheimer's disease : JAD.
[54] The molecular genetics of Alzheimer's disease , 1994 .
[55] R. Neve,et al. Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression , 2010, Biological Psychiatry.
[56] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[57] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[58] T. Foster,et al. Reversal of Age-Related Alterations in Synaptic Plasticity by Blockade of L-Type Ca2+ Channels , 1998, The Journal of Neuroscience.
[59] R. Mrak,et al. Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[60] E. Lein,et al. Transcriptional profiling reveals strict boundaries between hippocampal subregions , 2001, The Journal of comparative neurology.
[61] R. Stoyanova,et al. Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. , 2007, The Journal of molecular diagnostics : JMD.
[62] K. Yaffe,et al. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. , 2007, Current Alzheimer research.
[63] Grace E. Stutzmann. Calcium Dysregulation, IP3 Signaling, and Alzheimer’s Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[64] F. Gage,et al. Potential use of neurotrophic agents in the treatment of neurodegenerative disorders. , 1990, Acta neurobiologiae experimentalis.
[65] Lars Bertram,et al. New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.
[66] Xinkun Wang,et al. Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability , 2010, Current genomics.
[67] Corinna Burger,et al. Region-Specific Genetic Alterations in the Aging Hippocampus: Implications For Cognitive Aging , 2010, Front. Ag. Neurosci..
[68] D. Price,et al. Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[69] A. Owen,et al. AGEMAP: A Gene Expression Database for Aging in Mice , 2007, PLoS genetics.
[70] E. Blalock,et al. Aging-Related Gene Expression in Hippocampus Proper Compared with Dentate Gyrus Is Selectively Associated with Metabolic Syndrome Variables in Rhesus Monkeys , 2010, The Journal of Neuroscience.
[71] P. Davies,et al. Mechanism-based treatments for Alzheimer's disease , 2009, Dialogues in clinical neuroscience.
[72] C. Norris,et al. Age‐associated changes in Ca2+‐dependent processes: Relation to hippocampal synaptic plasticity , 1997 .
[73] E. Blalock,et al. A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease. , 2007, Current Alzheimer research.
[74] Y. Benjamini,et al. More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.
[75] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[76] D. Price,et al. Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.
[77] E. Masliah,et al. Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.
[78] Richard D. Kennedy,et al. RNA expression analysis from formalin fixed paraffin embedded tissues , 2008, Histochemistry and Cell Biology.
[79] J. Simpkins,et al. Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology , 2005, Annals of the New York Academy of Sciences.
[80] J. Ambati. Age-related macular degeneration and the other double helix. The Cogan Lecture. , 2011, Investigative ophthalmology & visual science.
[81] Eric M Reiman,et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.